Skip to main content

Animations

MJFF Publications

3291 - 3300 of 9131 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2024
  • 2024
  • 2023
  • 2019
  • 2024
  • 2024
  • 2023
  • 2020
  • Summary Details
    OPEN
    Title: Ligand-based design of [18F]OXD-2314 for PET imaging in non-Alzheimer’s disease tauopathies
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-024-49258-1
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Genetic and pharmacological reduction of CDK14 mitigates synucleinopathy
    Journal Name: Cell Death & Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41419-024-06534-8
    Citation Count: 8
  • Summary Details
    OPEN
    Title: LRRK2 kinase inhibition reverses G2019S mutation-dependent effects on tau pathology progression
    Journal Name: Translational Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40035-024-00403-2
    Citation Count: 23
  • Summary Details
    OPEN
    Title: A STING–CASM–GABARAP pathway activates LRRK2 at lysosomes
    Journal Name: Journal of Cell Biology
    Publisher: Rockefeller University Press
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1083/jcb.202310150
    Citation Count: 43
  • Summary Details
    OPEN
    Title: Genome-wide screen reveals Rab12 GTPase as a critical activator of Parkinson’s disease-linked LRRK2 kinase
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.87098
    Citation Count: 74
  • Summary Details
    OPEN
    Title: Reduced habit-driven errors in Parkinson’s Disease
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-019-39294-z
    Citation Count: 16
  • Summary Details
    OPEN
    Title: iATPSnFR2: A high-dynamic-range fluorescent sensor for monitoring intracellular ATP
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1073/pnas.2314604121
    Citation Count: 74
  • Summary Details
    OPEN
    Title: Neuroprotection of low dose carbon monoxide in Parkinson’s disease models commensurate with the reduced risk of Parkinson’s among smokers
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41531-024-00763-6
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Neuroprotective actions of a fatty acid nitroalkene in Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00502-3
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Towards defining reference materials for measuring extracellular vesicle refractive index, epitope abundance, size and concentration
    Journal Name: Journal of Extracellular Vesicles
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1080/20013078.2020.1816641
    Citation Count: 140
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.